CIP
AMRX icon

Chartwell Investment Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Chartwell Investment Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$686K Buy
82,410
+14,477
+21% +$113K 0.02% 382
2024
Q2 		$432K Buy
+67,933
New +$431K 0.02% 401

Other funds holding AMRX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chartwell Investment Partners's AMRX Position: Q3 2024 in Review

Chartwell Investment Partners increased its Amneal Pharmaceuticals (AMRX) stake by 21% in Q3 2024, buying an estimated $113K and bringing the position to 82,410 shares worth $686K. The position accounts for 0.02% of the portfolio, ranked #382.

Chartwell Investment Partners first reported a position in AMRX in Q2 2024 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold AMRX as of Q3 2024.

  • Chartwell Investment Partners held 82,410 shares of Amneal Pharmaceuticals worth $686K as of Q3 2024.
  • Chartwell Investment Partners bought 14,477 Amneal Pharmaceuticals shares in Q3 2024, an estimated $113K.
  • Amneal Pharmaceuticals made up 0.02% of Chartwell Investment Partners's portfolio in Q3 2024, its #382 holding.
  • Chartwell Investment Partners first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.